Nkoua Epala B¹*, Bolenga Liboko AF⁴, Bintsené Mpika G², Mbongo A², Ndounga E⁴, Ngatali SF⁴, Moyikoua R³ and Nsondé Malanda J⁴

¹Radiotherapy Service, CHU Brazzaville, Republic of the Congo
²Gynecology-Obstetrics Department, CHU Brazzaville, Republic of the Congo
³Radiology Department, CHU Brazzaville, Republic of the Congo
⁴Medical Oncology Department, CHU Brazzaville, Republic of the Congo

*Corresponding Author: Nkoua Epala B, Radiotherapy Service, CHU Brazzaville, Republic of the Congo.

Received: May 13, 2021; Published: May 26, 2021

Abstract

  Cervical cancer is the second most common female cancer after breast cancer in developing countries including Congo. Patients are diagnosed in most cases in the advanced stages and are treated in a standard way by concomitant radio chemotherapy.

  After the treatment of cervical cancers by radiotherapy, surveillance is an important stage in life after irradiation because it can either detect and treat the late effects of irradiation, detect and treat early a possible tumor recurrence, or reassure patients of the possibility of complete remission or cure. Radiation monitoring is clinical and radiological.

  It was a good opportunity for us to take stock of the surveillance of patients with radiotherapy at the University Hospital Centre (CHU) in Brazzaville and abroad for cervical cancer.

Keywords: Surveillance; Radiation Therapy; Cancer; Breast; Treatment

References

1. Barillot I., et al. “Complications of treatment of invasive cervical cancers on intact uterus. Results andprevention”. Cancer/Radiotherapy 4 (2000): 147-158.
2. Davidson SE., et al. “The impact of radiotherapy for carcinoma of the cervix on sexual function assessed using the LENT-SOMA scales”. Radiotherapy Oncology 68 (2003): 241-247.
3. Ngomo KMJ., et al. “Evaluation of cervical cancer management by tele-cobalt at the Libreville Hospital Center”. Médecine d'Afrique Noire 5111 (2004): 579-584.
4. Ozsaran Z., et al. “Radiochemotherapy for patients with locally advanced cervical cancer: early results”. European Journal of Gynaecological Oncology 2 (2003): 191-194.
5. Jensen PT., et al. “Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer”. International Journal of Radiation Oncology • Biology • Physics 56 (2003): 937-949.
6. Caffo O., et al. “Physical side effects and quality of life during postoperative radiotherapy for uterine cancer. Prospective evaluation by a diary card”. Gynecologic Oncology 88 (2003): 270-276.
7. Seiwert TY., et al. “The concurrent chemoradiation paradigm-general principles”. Nature Reviews Clinical Oncology 2 (2007): 86-100.
8. Barillot I and Haie-Meder C. “Association of radiotherapy and chemotherapy in gynecological cancers”. Bulletin Cancer 96 (2009): 271-283.
9. Barbera L and Thomas G. “Management of early and locally advanced cervical”. Seminar on Oncology 36 (2009): 155-169.
10. Joly-Lobbedez F. “Concomitant chemotherapie in cervical cancers: what levels of evidence?” Cancer/Radiotherapie 13 (2009): 503-506.
11. Green JA., et al. “Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix :a systematic review and meta-analysis”. Lancet 358 (2001): 781-786.
12. Lukka H., et al. “Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer - a meta analysis”. Clinical Oncology 14 (2002): 203-212.
13. Sheu MH., et al. “Preoperative staging of cervical carcinoma with MR imaging: a reappraisal of diagnostic accuracy and pitfalls”. European Radiology9 (2001): 182833.
14. Sala E., et al. “The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know”. Radiology3 (2013): 71740.
15. Sahdev A., et al. “The performance of magnetic resonance imaging in early cervical carcinoma: a long-term experience”. International Journal of Gynecological Cancer 3 (2007): 62936.
16. Jeong BK., et al. “Indications for endoscopy according to the revised FIGO staging for cervical cancer after MRI and CT scanning”. Gynecologic Oncology2 (2012): 805.
17. Loft A., et al. “The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study”. Gynecologic Oncology1 (2007): 2934.
18. Badoual C., et al. “[HPV (Human Papilloma Virus) involvement in other cancers than gynaecological]”. Rev Internal Medicine Founded by Natl French Society Internal Medicine8 (2015): 5407.
19. Mota F. “Microinvasive squamous carcinoma of the cervix: treatment modalities”. Acta Obstetricia et Gynecologica Scandinavica 6 (2003): 5059.
20. Lécuru F., et al. “Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study”. Journal of Clinical Oncology 13 (2011): 168691.
21. Kadkhodayan S., et al. “Sentinel node biopsy for lymph nodal staging of uterine cervix cancer: a systematic review and meta-analysis of the pertinent literature”. European Journal of Surgical Oncology 1 (2015): 120.
22. Zhou J., et al. “Robotic vs laparoscopic radical hysterectomy for cervical cancer: a meta-analysis”. International Journal of Medical Robotics and Computer Assisted Surgery 30 (2015).
23. Ramirez PT., et al. “Management of low-risk early-stage cervical cancer: should conization, simple trachelectomy, or simple hysterectomy replace radical surgery as the new standard of care?” Gynecologic Oncology1 (2004): 2549.
24. Ngô C., et al. “Outcome in early cervical cancer following pre-operative low dose rate brachytherapy: a ten-year follow up of 257 patients treated at a single institution”. Gynecologic Oncology2 (2011): 24852.

Citation

Citation: Nkoua Epala B., et al. “Monitoring of Patients Treated with Radiotherapy for Cervical Cancer”. Acta Scientific Cancer Biology 5.6 (2021): 44-48.

Copyright

Copyright: © 2021 Nkoua Epala B., et al.. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.